Secreted Phospholipase A2 Group X Acts as an Adjuvant for Type 2 Inflammation, Leading to an Allergen-Specific Immune Response in the Lung
Open Access
- 27 April 2020
- journal article
- research article
- Published by Oxford University Press (OUP) in The Journal of Immunology
- Vol. 204 (12) , 3097-3107
Abstract
Secreted phospholipase A2 (sPLA2) enzymes release free fatty acids, including arachidonic acid, and generate lysophospholipids from phospholipids, including membrane phospholipids from cells and bacteria and surfactant phospholipids. We have shown that an endogenous enzyme sPLA2 group X (sPLA2-X) is elevated in the airways of asthmatics and that mice lacking the sPLA2-X gene (Pla2g10) display attenuated airway hyperresponsiveness, innate and adaptive immune responses, and type 2 cytokine production in a model of airway sensitization and challenge using a complete allergen that induces endogenous adjuvant activity. This complete allergen also induces the expression of sPLA2-X/Pla2g10. In the periphery, an sPLA2 found in bee venom (bee venom PLA2) administered with the incomplete Ag OVA leads to an Ag-specific immune response. In this study, we demonstrate that both bee venom PLA2 and murine sPLA2-X have adjuvant activity, leading to a type 2 immune response in the lung with features of airway hyperresponsiveness and Ag-specific type 2 airway inflammation following peripheral sensitization and subsequent airway challenge with OVA. Further, the adjuvant effects of sPLA2-X that result in the type 2–biased OVA-specific adaptive immune response in the lung were dependent upon the catalytic activity of the enzyme, as a catalytically inactive mutant form of sPLA2-X does not elicit the adaptive component of the immune response, although other components of the immune response were induced by the inactive enzyme, suggesting receptor-mediated effects. Our results demonstrate that exogenous and endogenous sPLA2s play an important role in peripheral sensitization, resulting in airway responses to inhaled Ags.Keywords
Funding Information
- National Heart, Lung, and Blood Institute (R01HL089215, F32HL134217)
- National Institute of Allergy and Infectious Diseases (K24AI130263, U19AI125378)
This publication has 52 references indexed in Scilit:
- Group X Secreted Phospholipase A2 Proenzyme Is Matured by a Furin-like Proprotein Convertase and Releases Arachidonic Acid inside of Human HEK293 CellsJournal of Biological Chemistry, 2011
- Phospholipase A2Enzymes: Physical Structure, Biological Function, Disease Implication, Chemical Inhibition, and Therapeutic InterventionChemical Reviews, 2011
- Blockade of Human Group X Secreted Phospholipase A2 (GX-sPLA2)-induced Airway Inflammation and Hyperresponsiveness in a Mouse Asthma Model by a Selective GX-sPLA2 InhibitorJournal of Biological Chemistry, 2011
- Dectin-2 mediates Th2 immunity through the generation of cysteinyl leukotrienesJournal of Experimental Medicine, 2011
- Relationship between levels of secreted phospholipase A2 groups IIA and X in the airways and asthma severityClinical & Experimental Allergy, 2011
- Eosinophil Cysteinyl Leukotriene Synthesis Mediated by Exogenous Secreted Phospholipase A2 Group XJournal of Biological Chemistry, 2010
- Group X Secretory Phospholipase A 2 Negatively Regulates ABCA1 and ABCG1 Expression and Cholesterol Efflux in MacrophagesArteriosclerosis, Thrombosis, and Vascular Biology, 2010
- Group III secreted phospholipase A2 transgenic mice spontaneously develop inflammationBiochemical Journal, 2009
- Honeybee venom secretory phospholipase A2 induces leukotriene production but not histamine release from human basophilsClinical and Experimental Immunology, 2007
- Importance of group X–secreted phospholipase A2 in allergen-induced airway inflammation and remodeling in a mouse asthma modelJournal of Experimental Medicine, 2007